University of Toledo Medical Center takes part in national drug study for COVID-19

January 6, 2021 | COVID-19, UToledo in the News, UTMC
By Staff

Dr. Michael Ellis, an infectious disease specialist and chief medical officer at UTMC, talks about hospital’s participation in a nationwide NIH study aimed at quickly and efficiently identifying additional therapeutics for COVID-19 worthy of larger clinical trials.

Click to access the login or register cheese